{"entity":{"type":"insider","cik":"0001685994","url":"/insider/0001685994","json_url":"/insider/0001685994.json","name":"Cumbo Alexander","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2017-07-21","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Cumbo Alexander","source":"filing","n_filings":11,"first_seen":"2017-07-21","last_seen":"2026-02-18"}],"transactions":[{"id":5904608,"accession":"0001193125-26-057878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-057878","line_url":"/filing/0001193125-26-057878#line-2","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16644.0,"shares_display":"16,644","price_per_share":5.8233,"price_display":"5.82","price_state":"stated","total_value":96923.0052,"total_display":"96,923.01","total_whole":"96,923","shares_owned_after":235405.0,"shares_owned_after_display":"235,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-18","scope":"insider"},{"id":5762183,"accession":"0001193125-26-041519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-041519","line_url":"/filing/0001193125-26-041519#line-1","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48913.0,"shares_display":"48,913","price_per_share":6.4419,"price_display":"6.44","price_state":"stated","total_value":315092.6547,"total_display":"315,092.65","total_whole":"315,093","shares_owned_after":222018.0,"shares_owned_after_display":"222,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":6072563,"accession":"0001193125-26-034087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-034087","line_url":"/filing/0001193125-26-034087#line-3","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80258.0,"shares_display":"80,258","price_per_share":6.4369,"price_display":"6.44","price_state":"stated","total_value":516612.7202,"total_display":"516,612.72","total_whole":"516,613","shares_owned_after":270931.0,"shares_owned_after_display":"270,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":4202450,"accession":"0001193125-25-308115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-308115","line_url":"/filing/0001193125-25-308115#line-2","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10808.0,"shares_display":"10,808","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":55228.88,"total_display":"55,228.88","total_whole":"55,229","shares_owned_after":81388.0,"shares_owned_after_display":"81,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4582300,"accession":"0000950170-25-022200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-022200","line_url":"/filing/0000950170-25-022200#line-2","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11365.0,"shares_display":"11,365","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":45005.4,"total_display":"45,005.40","total_whole":"45,005","shares_owned_after":60717.0,"shares_owned_after_display":"60,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-18","scope":"insider"},{"id":2125782,"accession":"0000950170-24-133360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-133360","line_url":"/filing/0000950170-24-133360#line-2","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11114.0,"shares_display":"11,114","price_per_share":5.5998,"price_display":"5.60","price_state":"stated","total_value":62236.1772,"total_display":"62,236.18","total_whole":"62,236","shares_owned_after":38484.0,"shares_owned_after_display":"38,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":8282408,"accession":"0000950170-23-068076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-068076","line_url":"/filing/0000950170-23-068076#line-2","is_derivative":false,"issuer_cik":"0001685994","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001685994","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11757.0,"shares_display":"11,757","price_per_share":2.7657,"price_display":"2.77","price_state":"stated","total_value":32516.3349,"total_display":"32,516.33","total_whole":"32,516","shares_owned_after":17439.0,"shares_owned_after_display":"17,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"},{"id":8210760,"accession":"0001209191-19-061050","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-061050","line_url":"/filing/0001209191-19-061050","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":125.5,"price_display":"125.50","price_state":"stated","total_value":5271000.0,"total_display":"5,271,000.00","total_whole":"5,271,000","shares_owned_after":11161.0,"shares_owned_after_display":"11,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-17","scope":"insider","n_lines":2},{"id":7865841,"accession":"0001209191-19-006634","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-006634","line_url":"/filing/0001209191-19-006634#line-3","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":2100000.0,"total_display":"2,100,000.00","total_whole":"2,100,000","shares_owned_after":15266.0,"shares_owned_after_display":"15,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-01","scope":"insider"},{"id":6455444,"accession":"0001209191-18-042389","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-042389","line_url":"/filing/0001209191-18-042389","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33782.0,"shares_display":"33,782","price_per_share":137.32,"price_display":"137.32","price_state":"stated","total_value":4638944.24,"total_display":"4,638,944.24","total_whole":"4,638,944","shares_owned_after":28766.0,"shares_owned_after_display":"28,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-11","scope":"insider","n_lines":3},{"id":5319842,"accession":"0001209191-17-046035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-046035","line_url":"/filing/0001209191-17-046035","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001685994","owner_name":"Cumbo Alexander","owner_display_name":"Cumbo Alexander","owner_url":"/insider/0001685994","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5918.0,"shares_display":"5,918","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":242638.0,"total_display":"242,638.00","total_whole":"242,638","shares_owned_after":16875.0,"shares_owned_after_display":"16,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001707502","name":"Solid Biosciences Inc.","url":"/issuer/0001707502","role":"Director, Officer (President and CEO)","n_filings":7,"first_seen":"2023-12-05","last_seen":"2026-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Officer (EVP, Chief Commercial Officer)","n_filings":4,"first_seen":"2017-07-21","last_seen":"2019-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001685994","retrieved_at":"2026-08-23T19:11:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}